Mutational and clinical features of Japanese patients with dysferlinopathy (Miyoshi myopathy and limb girdle muscular dystrophy type 2B)

Clinical Neurology

Volumn 45, Issue 11, 2005, Pages 938-942

  Aoki, Masashi ^a   Takahashi, Toshiaki ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dysferlin; LGMD; Limb girdle muscular dystrophy; Miyoshi myopathy; Mutation

Indexed keywords

CREATINE KINASE; DYSFERLIN;

ADOLESCENT; ADULT; CLINICAL FEATURE; CONFERENCE PAPER; CREATINE KINASE BLOOD LEVEL; DISEASE DURATION; DISEASE SEVERITY; DYSFERLINOPATHY; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; JAPAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MIYOSHI MYOPATHY; MUSCULAR DYSTROPHY; ONSET AGE; SCHOOL CHILD; WALKING AID; WHEELCHAIR;

ADOLESCENT; ADULT; CHILD; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; MUSCLE PROTEINS; MUSCULAR DYSTROPHIES; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MUTATION;

EID: 31544451532     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Miyoshi K, Kawai H, Iwasa M, et al: Autosomal recessive distal muscular dystrophy as a new type of progressive muscular dystrophy. Brain 1986; 109: 31-54
2. Liu J, Aoki M, Illa I, et al: Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nature Genet 1998; 20: 31-36
3. Bashir R, Britton S, Strachan T, et al: A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nature Genet 1998; 20: 37-42
4. Illa I, Serrano-Munuera C, Gallardo E, et al: Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol 2001; 49: 130-134
5. Annual Review, 2005. pp 277-283
6. Aoki M, Liu J, Richard I, et al: Genomic organization and novel mutations in the dysferlin gene in Miyoshi myopathy. Neurology 2001; 57: 271-278
7. Anderson LV, Davison K, Moss JA, et al: Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet 1999; 8: 855-861
8. Matsuda C, Aoki M, Hayashi YK, et al: Dysferlin is a surface membrane-associated protein that is absent in Miyoshi myopathy. Neurology 1999; 53: 1119-1122
9. Matsuda C, Hayashi YK, Ogawa M, et al: The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Hum Mol Genet 2001; 10: 1761-1766
10. Matsuda C, Kameyama K, Tagawa K, et al: Dysferlin interacts with affixin (beta-parvin) at the sarcolemma. J Neuropathol Exp Neurol 2005; 64: 334-340
11. Takahashi T, Aoki M, Tateyama M, et al: Dysferlin mutations in Japanese Miyoshi myopathy: Relationship to phenotype. Neurology 2003; 60: 1799-1804
12. Suzuki N, Aoki M, Takahashi T, et al: Novel dysferlin mutations and characteristic muscle atrophy in late-onset Miyoshi myopathy. Muscle Nerve 2004; 29: 721-723
13. Takahashi T, Aoki M, Tateyama M, et al: Mutational and Clinical Features of Japanese Patients with Dysferlinopathy (abstr). Neurology 2003; 60: A233 Suppl.
14. Tagawa K, Ogawa M, Kawabe K, et al: Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients. J Neurol Sci 2003; 211: 23-28
15. Saito A, Higuchi I, Nakagawa M, et al: Miyoshi myopathy patients with novel 5′ splicing donor site mutations showed different dysferlin immunostaining at the sarcolemma. Acta Neuropathol (Berl) 2002; 104: 615-620